Triglyceride Forum

[Triglyceride Forum @TriglycerideF]

New data from CORE-TIMI72a & CORE2-72b trials reported at #EAS2026 highlighted that #Olezarsen reduces risk of #AcutePancreatitis in people with very high #triglyceride levels.

Find out more on Triglyceride Forum…
https://t.co/mtj5WcRLkR

#apoC3 @AndreZimerman @TIMIStudyGroup

[Triglyceride Forum @TriglycerideF]

View #EASCongress2026 highlights on #Triglyceride Forum: Novel TG-lowering therapies, plus concerning evidence of low TG testing after #AcutePancreatitis. Better TG testing is vital to identify patients who may benefit from emerging treatments. Read more >https://t.co/2njPB7946G

[Triglyceride Forum @TriglycerideF]

Leading molecular medicine expert Daniel Rader explains how #APOCIII loss-of-function variants improve #triglyceride clearance, affect apoB lipoprotein metabolism, and may lower coronary artery disease risk. https://t.co/kYzdkd4KkV

@PennMedicine @Penn #lipidology #cardiology

[Triglyceride Forum @TriglycerideF]

Severely elevated #triglycerides put patients at real risk of acute pancreatitis. New data highlighted on Triglyceride Forum show a novel therapy lowering TGs—and reducing recurrent #pancreatitis risk.

Worth a closer look >> https://t.co/gLyRyxGpBB

#Plozasiran @StanfordDeptMed

[Triglyceride Forum @TriglycerideF]

Would patients with elevated triglyceride-rich lipoprotein cholesterol who are taking a #statin benefit from additional treatment with a #fibrate drug? Find out what research shows on #Triglyceride Forum…https://t.co/K7zLmUaf28

#TRLC #cardiologists #lipidologists @UCPH_Research

[Triglyceride Forum @TriglycerideF]

Severe & extreme #hypertriglyceridaemia raise risks of acute #pancreatitis and CV events—especially at younger ages. Real-world US data (~3,800 pts, #ACC26) underscores need for earlier, targeted management to cut lifetime risk. Read more > https://t.co/xAW6ec5qO8

#cardioTwitter

[Triglyceride Forum @TriglycerideF]

A 2nd substudy from the Essence-TIMI 73b trial (#ACC26) shows #olezarsen lowers #triglycerides more in patients already on #fibrates vs those not on them. Explore results and possible mechanisms on Triglyceride Forum: https://t.co/2aLzyPE74h
https://t.co/2aLzyPE74h

[Lpa Forum @LpaForum]

Could eicosapentaenoic acid (#EPA) reduce #CVrisk via Lp(a) as well as TG lowering seen in REDUCE-IT trial? New #ACC26 data suggest EPA’s antioxidant effects on #Lpa may help. Learn more on @LpaForum:
https://t.co/Qu9T0jTeYa
#lipidologists #cardiologists @TriglycerideF @DLBHATTMD

[Triglyceride Forum @TriglycerideF]

New data on #plozasiran shows sustained #triglyceride lowering and strong safety across severe & moderate HTG (SHASTA-2 OLE, MUIR). Now entering US clinical use for FCS. Learn more about insights presented at #ACC26 by @CBallantyneMD on Triglyceride Forum:
https://t.co/wXid1cnLOJ

[Triglyceride Forum @TriglycerideF]

12 months of #triglyceride lowering didn’t slow #plaqueprogression in ESSENCE-TIMI 73b. Short duration + strong background therapy may explain it—but we still need long-term outcomes trials to prove real #cardiovascular benefit.

Learn more: https://t.co/gVhTm0oJ0b

@marstonMD

[Triglyceride Forum @TriglycerideF]

#Triglycerides took centre stage at #ACC26: new data on lowering TGs to slow plaque progression, long-term use of novel therapies & links between very high TGs, #CVrisk & acute #pancreatitis.

Find out more >> https://t.co/veRQwJQ1R9

#cardiologists #lipidologists

[Triglyceride Forum @TriglycerideF]

Research suggests #olezarsen may reduce healthcare use in familial chylomicronaemia syndrome—fewer/shorter hospital stays, fewer ER visits and positive patient feedback. Larger studies could inform funding decisions. Read more on Triglyceride Forum > https://t.co/p3biPHBY60

#FCS

[Triglyceride Forum @TriglycerideF]

#Triglyceride lowering agent #pemafibrate may improve #liverfibrosis, #lipidmetabolism & #liverenzyme levels in those with #fattyliverdisease & raised triglyceride levels, read more on Triglyceride Forum > https://t.co/izY0Zls1k3

#NationalTriglycerideDay
https://t.co/izY0Zls1k3

[Triglyceride Forum @TriglycerideF]

Keep up to date with the latest #triglyceride-related #ClinicalTrials. Don’t miss the data shaping future care... https://t.co/CmEAWjU8ZG

For #clinicians, #researchers & the whole CV care team.
#cardiologists #lipidologists #GPs #nurses #pharmacists #ClinicalResearch

[Triglyceride Forum @TriglycerideF]

𝗜𝗼𝗮𝗻𝗻𝗮 𝗚𝗼𝘂𝗻𝗶-𝗕𝗲𝗿𝘁𝗵𝗼𝗹𝗱 considers key questions and potential inclusion criteria for future CV outcomes trials with novel agents that have shown significantly greater #triglyceride-lowering effects than current therapies >> https://t.co/dWqAepDSJz
@UKKoeln

[Triglyceride Forum @TriglycerideF]

New US #dyslipidaemia guidelines highlight the importance of managing elevated #triglycerides. Triglyceride Forum summarises the key advice on #CVrisk assessment, diet, lifestyle, and treatments. Read more: https://t.co/bADTEPgBcK

#icosapentethyl #apoCIII #olezarsen

[Triglyceride Forum @TriglycerideF]

Watch Dr Matthew Budoff, David Geffen School of Medicine at UCLA discuss imaging data supporting the benefits of #eicosapentaenoic acid on #plaque regression, compared with the effects of #fibrates and #PCSK9 inhibitors >>
https://t.co/HW6VDty6ok

@BudoffMd @UCLA

[Triglyceride Forum @TriglycerideF]

Dr Nicholas Marston reviews clinical trial results for #apoC3-targeted agents in patients with #hypertriglyceridaemia and considers implications for patients at risk of #AcutePancreatitis on #Triglyceride Forum >> https://t.co/pjsY5Z0pqN

@marstonMD @BrighamWomens #lipidTwitter

[Triglyceride Forum @TriglycerideF]

View latest video presentations by leading #lipid specialists, Dr Nicholas Marston, Professor Matthew Budoff and Professor Ioanna Gouni-Berthold, given at the Forum’s 11th Closed Scientific Expert Meeting: https://t.co/J6HaOC7nGt
#apoC3 #triglyceride @marstonMD @BudoffMd @UKKoeln

[Triglyceride Forum @TriglycerideF]

Watch Dr Sander Kersten present the evidence for the effects of loss of #ANGPTL4 activity on #triglyceride levels in liver and adipose tissue and discuss the implications for novel therapies targeting ANGPTL4, on Triglyceride Forum >> https://t.co/hkOQmOVzCa

@Cornell